3 withdrawn. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Withdrawn 3 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Vasculitis: new trials by email Literature Review of Vasculitis trials Research Report on Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease IVIG, Aspirin, Infliximab - Kawasaki Disease | Phase 3 | Withdrawn | Children's Hospital of Fudan University | 2020-10-01 | 2021-03-12 | |
| PROphylaxis for paTiEnts at Risk of COVID-19 infecTion Hydroxychloroquine Sulfate 200 MG - COVID-19 | Phase 2 / Phase 3 | Withdrawn | Cambridge University Hospitals NHS Foundation Trust | 2020-09-01 | 2021-03-08 | |
| A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA) Abatacept, Placebo, Glucocorticoid Treatment - Giant Cell Arteritis | Phase 3 | Withdrawn | Bristol-Myers Squibb | 2017-07-15 | 2017-07-12 |
COVID-19 (1) · Giant Cell Arteritis (1) · Mucocutaneous Lymph Node Syndrome (1)
Cardiovascular Diseases (3) · Vascular Diseases (3) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Arteritis (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Hemic and Lymphatic Diseases (1)
Abatacept (1) · Aspirin (1) · Hydroxychloroquine (1) · Immunoglobulins, Intravenous (1) · Infliximab (1)
Bristol-Myers Squibb (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Children's Hospital of Fudan University (1)
Australia (1) · Austria (1) · Belgium (1) · Bulgaria (1) · Canada (1) · China (1) · Denmark (1) · Estonia (1) · France (1) · Germany (1) · Greece (1) · Ireland (1) · Italy (1) · Netherlands (1) · Poland (1)
Guoying Huang, MD. (1) · Thomas Hiemstra, PhD (1)
2016 (1)